Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer

Pediatric Blood and Cancer

Volumn 48, Issue 3, 2007, Pages 273-277

  Quezada, Gerardo ^a   Sunderland, Theresa ^a   Ka, Wah Chan ^b   Rolston, Kenneth ^a   Mullen, Craig A ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS TRANSPLANT INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Fever and neutropenia; Pediatric cancer; Supportive care

Indexed keywords

AZITHROMYCIN; CEFEPIME; CIPROFLOXACIN; TROVAFLOXACIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; COMORBIDITY; DRUG SUBSTITUTION; FEBRILE NEUTROPENIA; FEVER; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INFECTION; LANGUAGE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; NEUTROPENIA; OUTPATIENT CARE; PAIN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; ATTITUDE; CLINICAL PROTOCOLS; COMMUNICATION BARRIERS; COMORBIDITY; FEVER; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFUSIONS, INTRAVENOUS; LANGUAGE; NEOPLASMS; NEUTROPENIA; OUTPATIENT CLINICS, HOSPITAL; PATIENT SELECTION; TEXAS;

EID: 33846901593     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20774     Document Type: Article

References (14)

1. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751.
2. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenias. N Engl J Med 1993;328:1323-1332.
3. Ammann RA, Hirt A, Luthy AR, et al. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004;23:61-67.
4. Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: A multi-national scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000;18:3038-3051.
5. Paganini H, Gomez S, Ruvinsky S, et al. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: A single-center, randomized, controlled trial in Argentina. Cancer 2003;97:1775-1780.
6. Hann I, Viscoli C, Paesmans M, et al. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC trials. Br J Haematol 1997;99:580-588.
7. Mullen CA, Petropoulos D, Roberts WM, et al. Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer. J Pediatr Hematol Oncol 1999;21:212-218.
8. Ammann RA, Hirt A, Luthy AR, et al. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 2003;41:436-443.
9. Aquino VM, Buchanan GR, Tkaczewski I, et al. Safety of early hospital discharge of selected febrile children and adolescents with cancer with prolonged neutropenia. Med Pediatr Oncol 1997;28:191-195.
10. Baorto EP. Aquino VM, Mullen CA, et al. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer 2001;92:909-913.
11. Klaassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000;18:1012-1019.
12. Mullen CA, Petropoulos D, Roberts WM, et al. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Cancer 1999;86:126-134.
13. Orudjev E, Lange BJ. Evolving concepts of management of febrile neutropenia in children with cancer. Med Pediatr Oncol 2002;39:77-85.
14. Aquino VM, Herrera L, Sandler ES, et al. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 2000;88:1710-1714.